Related Experiment Video
Updated: May 5, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Telemedicine in Pediatric Diabetes Care: The Way Forward?
Lokesh Sharma1, Eshita Bhowmik1, Zebish Ali1
1Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Telemedicine effectively managed type 1 diabetes (T1D) in India, improving glycemic control and knowledge. This approach offers feasible outreach care, reducing costs and time for families managing T1D.
Area of Science:
- Endocrinology
- Digital Health
- Public Health
Background:
- Limited data exists on telemedicine's efficacy for type 1 diabetes (T1D) in India.
- Outreach care models are crucial for managing chronic conditions in diverse settings.
Purpose of the Study:
- To assess the non-inferiority of glycemic control in T1D patients using telemedicine.
- To evaluate the impact of telemedicine on diabetes knowledge scores.
- To determine the feasibility and cost-effectiveness of tele-diabetes care in India.
Main Methods:
- A study involving 59 individuals with T1D (age ≤ 25 years) was conducted.
- Paramedical staff provided routine care at outreach centers.
- Physician consultations were delivered via Zoom, with assessments at 6 months.
Main Results:
- Significant reduction in HbA1c levels from 8.47% to 8.0% (P=0.043).
- Diabetes knowledge scores improved significantly from 61.2 to 64.9 (P=0.022).
- Families saved a median of Rs 1500 and 10 hours per visit.
Conclusions:
- Tele-diabetes care is effective for managing T1D in the Indian context.
- Telemedicine facilitates outreach care delivery by multidisciplinary teams.
- This model demonstrates feasibility, improved patient outcomes, and resource savings.
Related Concept Videos
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

